✦ LIBER ✦

Neuroendocrine differentiation and the bombesin/gastrin-releasing peptide family of neuropeptides in the progression of human prostate cancer

✍ Scribed by Aprikian, Armen G.; Han, Kehan; Guy, Laurent; Landry, France; Begin, Louis R.; Chevalier, Simone

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 486 KB
Volume: 36
Category: Article
ISSN: 0270-4137
DOI: 10.1002/(sici)1097-0045(1998)8+<52::aid-pros9>3.0.co;2-i

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Presence of receptors for bombesin/gastr

Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancers

✍ Sun, Baodong; Halmos, Gabor; Schally, Andrew V.; Wang, Xiaofei; Martinez, Miriam 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB 👁 1 views

BACKGROUND. Bombesin-like peptides can function as autocrine or paracrine growth factors and stimulate the growth of some cancer cells, including human prostate cancer. Three bombesin receptor subtypes, termed gastrin-releasing peptide receptor (GRPR), neuromedin B receptor (NMBR), and bombesin rece

Differential expression of the CCK-A and

Differential expression of the CCK-A and CCK-B/gastrin receptor genes in human cancers of the esophagus, stomach and colon

✍ Pascal Clerc; Marlène Dufresne; Corinne Saillan; Eric Chastre; Thierry André; Ch 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 107 KB 👁 1 views

Tumor localization of a radiolabeled bom

Tumor localization of a radiolabeled bombesin analogue in mice bearing human ovarian tumors induced to express the gastrin-releasing peptide receptor by an adenoviral vector

✍ Buck E. Rogers; David T. Curiel; Matthew S. Mayo; Kim K. Laffoon; Sheila J. Brig 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

## METHODS. Human ovarian cancer cells (SKOV3.ip1) were infected in vitro with AdCMVGRPr and were assayed for receptor expression at 2, 4, and 7 days after 2 Department of Medicine, Comprehensive Caninfection by using a radiolabeled bombesin-binding assay. Biodistribution studies cer Center, Unive

Potentiation of the inhibitory effect of

Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways

✍ Artur Plonowski; Andrew V. Schally; Jozsef L. Varga; Zoltan Rekasi; Francine Heb 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB

Bombesin/gastrin-releasing peptide antag

Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma

✍ Miklós Koppán; Gábor Halmos; José M. Arencibia; Najib Lamharzi; Andrew V. Schall 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

## BACKGROUND. Antagonists of bombesin/gastrin-releasing peptide (BN/GRP) have been developed to block the autocrine stimulatory effect of BN/GRP on tumors such as small cell lung carcinoma (SCLC). Although several studies have addressed the intracellular events that follow the formation of the re

Targeted cytotoxic analog of luteinizing

Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits the growth of PC-82 human prostate cancer in nude mice

✍ Kopp�n, Miklos; Nagy, Attila; Schally, Andrew V.; Plonowski, Artur; Halmos, G�bo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB 👁 1 views

## Background: Receptors for luteinizing hormone-releasing hormone (lh-rh) found in prostate cancers might be used for targeting of chemotherapeutic agents. doxorubicin derivative 2-pyrrolinodoxorubicin (an-201) can be linked to carrier analog [d-lys6]lh-rh to form the targeted cytotoxic analog of